Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis
Rheumatology International Oct 23, 2017
Sun Y, et al. - The objective of this study is to evaluate the efficacy of cyclophosphamide (CYC) versus methotrexate (MTX) for active TakayasuÂs arteritis (TA). The outcome of this study suggests that the cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
